Clinical response to onabotulinumtoxina injection therapy for treatment-refractory chronic migraine: "real world" experience

被引：0
|
作者：
Rothrock, J. [1 ]
Andress-Rothrock, D. [1 ]
Hanlon, C. [1 ]
Weibelt, S. [1 ]
机构：
[1] Univ Alabama Birmingham, Sch Med, Neurol, Birmingham, AL USA
来源：
CEPHALALGIA | 2011年 / 31卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
PS1-190
引用
收藏
页码：101 / 101
页数：1
相关论文
共 50 条
  • [31] OnabotulinumtoxinA for chronic migraine: a real-life Italian multicenter experience
    Vernieri, Fabrizio
    Paolucci, Matteo
    Altamura, Claudia
    Pasqualetti, Patrizio
    Mastrangelo, Vincenzo
    Pierangeli, Giulia
    Cevoli, Sabina
    D'Amico, Domenico
    Grazzi, Licia
    NEUROLOGICAL SCIENCES, 2018, 39 : S171 - S172
  • [32] Real-world experience of OnabotulinumtoxinA treatment in female patients with chronic migraine: a qualitative study using in-depth interviews
    Palacios-Cena, Domingo
    Ordas-Bandera, Carlos
    Casas-Limon, Javier
    Perez-Corrales, Jorge
    Gueita-Rodriguez, Javier
    Arias-Navalon, Jose A.
    Cuadrado, Maria-Luz
    ANNALS OF MEDICINE, 2023, 55 (02)
  • [33] Real-world economic impact of onabotulinumtoxina in patients with chronic migraine
    Rothrock, J. F.
    Bloudek, L. M.
    Houle, T. T.
    Andress-Rothrock, D.
    Hanlon, C.
    Varon, S. F.
    JOURNAL OF HEADACHE AND PAIN, 2013, 14
  • [34] OnabotulinumtoxinA for chronic migraine: a real-life Italian multicenter experience
    Fabrizio Vernieri
    Matteo Paolucci
    Claudia Altamura
    Patrizio Pasqualetti
    Vincenzo Mastrangelo
    Giulia Pierangeli
    Sabina Cevoli
    Domenico D’Amico
    Licia Grazzi
    Neurological Sciences, 2018, 39 : 171 - 172
  • [35] PILOT STUDY OF SPHENOPALATINE INJECTION OF ONABOTULINUMTOXINA FOR THE TREATMENT OF INTRACTABLE CHRONIC MIGRAINE
    Bratbak, D.
    Nordgard, S.
    Stovner, L. J.
    Linde, M.
    Dodick, D. W.
    Aschehoug, I.
    Folvik, M.
    Vidal, J. Crespi
    Tronvik, E.
    CEPHALALGIA, 2016, 36 : 18 - 18
  • [36] Pilot study of sphenopalatine injection of onabotulinumtoxinA for the treatment of intractable chronic migraine
    Bratbak, Daniel Fossum
    Nordgard, Stale
    Stovner, Lars Jacob
    Linde, Mattias
    Dodick, David W.
    Aschehoug, Irina
    Folvik, Mari
    Tronvik, Erling
    CEPHALALGIA, 2017, 37 (04) : 356 - 364
  • [37] Real-world evidence for the safety and efficacy of CGRP monoclonal antibody therapy added to OnabotulinumtoxinA treatment for migraine prevention in adult patients with chronic migraine
    Mechtler, L. L.
    Saikali, N. P.
    McVige, J.
    Hughes, O.
    Traut, A.
    Adams, A.
    HEADACHE, 2021, 61 : 176 - 177
  • [38] Real-world Evidence for the Safety and Efficacy of CGRP Monoclonal Antibody Therapy Added to OnabotulinumtoxinA Treatment for Migraine Prevention in Adult Patients with Chronic Migraine
    Mechtler, L.
    Saikali, N.
    McVige, J.
    Hughes, O.
    Traut, A.
    Adams, A.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 48 - 49
  • [39] Real-World Evidence for the Safety and Efficacy of CGRP Monoclonal Antibody Therapy Added to OnabotulinumtoxinA Treatment for Migraine Prevention in Adult Patients With Chronic Migraine
    Mechtler, Laszlo
    Saikali, Nicolas
    McVige, Jennifer
    Hughes, Olivia
    Traut, Alexandra
    Adams, Aubrey
    TOXICON, 2022, 214 : S39 - S40
  • [40] Real-World Evidence for the Safety and Efficacy of CGRP Monoclonal Antibody Therapy Added to OnabotulinumtoxinA Treatment for Migraine Prevention in Adult Patients With Chronic Migraine
    Mechtler, Laszlo
    Saikali, Nicolas
    McVige, Jennifer
    Hughes, Olivia
    Traut, Alexandra
    Adams, Aubrey Manack
    FRONTIERS IN NEUROLOGY, 2022, 12
12345